ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
The EspeRare Foundation, Pierre Fabre to Develop XLHED Treatment
January 05, 2021The EspeRare Foundation and the Pierre Fabre group have entered into a license and development collaboration agreement for the development and commercialization of ER-004, a prenatal treatment for XLHED (X-linked Hypohidrotic Ectodermal Dysplasia) ... -
Global Respiratory Clinics Market will grow at a CAGR of 20.7% over the forecast period - says Absolute Markets Insights
December 14, 2020The EspeRare Foundation and the Pierre Fabre group announced today that they have entered into a license and development collaboration agreement for the development and commercialization of ER-004, a prenatal treatment for XLHED (X-linked Hypohidrotic ...
Pharma Sources Insight January 2025
